跳到主要內容

Broadrick Dale 的 Form 4 申報

BioRestorative Therapies, Inc.(BRTX),2022/6/7 申報

申報編號
0001567619-22-012430
申報時間
2022/6/7
交易日
2022/6/3-6/6
申報延遲
4 天
10b5-1 計畫
表單沒有這欄(2023 年以前)

這份申報列了 2 筆非衍生性交易。公開市場買進合計 $2.07 萬。交易後 4 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Broadrick DaleCIK 0001677513持股 10% 以上大股東

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/6/3Common StockP買進取得+1,200$4.90F1+$5,880279,673直接
2022/6/6Common StockP買進取得+3,000$4.93F2+$14,790282,673直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

This transaction was executed in multiple trades at prices ranging from $4.80 to $4.9199 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

F2

This transaction was executed in multiple trades at prices ranging from $4.8531 to $4.9676 per share. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transactions were effected.

表 I 有 1 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)